Strategic Intelligence

   Operationally informed diligence for people making high-stakes decisions in life sciences.

Intro

Life sciences assets are rarely as straightforward as they appear in a deck. EHG provides strategic intelligence services that help investors, operators, and decision-makers evaluate clinical and operational realities with more depth, context, and confidence.

What We Deliver

Our work is designed for hedge funds, private equity firms, family offices, strategic investors, and operating teams that need insight beyond surface-level diligence. We bring together experience in trial execution, site operations, patient engagement, recruitment realities, protocol feasibility, and market context to assess opportunities through a practical lens.

Areas of Focus

• Clinical and operational diligence
• Assessment of research feasibility and execution risk
• Evaluation of patient access, recruitment, and enrollment assumptions
• Review of infrastructure readiness and partner dependencies
• Strategic perspective on how operational realities may affect value creation

Why EHG Is Different

Many diligence processes rely heavily on financial or scientific abstractions. EHG adds grounded operating insight—how a study may actually run, where a program may stall, what assumptions are too optimistic, and which patient or site realities could materially affect outcomes.

Who We Support

Institutional investors evaluating assets

Life sciences executives pressure-testing strategic decisions

Teams seeking a more operational view of risk, readiness, and opportunity

When the decision is high stakes, practical insight matters. EHG helps clients see beyond the headline and into the realities that drive outcomes.